Skip to main content
LYEL logo

Lyell Immunopharma, Inc.

LYELNASDAQHealthcareBiotechnology

$9.31Today:- (-)1Y −48.80%

As of Oct 26, 2026 close

Market cap
$217.52M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$7.20$45.00
Volume (live)
-
Avg. volume (3M)
167.76K

Lyell Immunopharma, Inc. (LYEL) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Lyell Immunopharma, Inc. stock.

Analyst Consensus Rating

Investment consensus from 5 professional research analysts

Consensus Rating

Buy
Based on 5 unique analysts
Medium Confidence4.0:1 Buy/Sell

Average Price Target

$36.20
+288.83% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest LYEL Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Yuan Zhi
B Riley
BuyMaintains
$44.00
Stephen Willey
Stifel Nicolaus
BuyMaintains
$36.00
Mitchell Kapoor
HC Wainwright
BuyReiterates
$45.00
Gil Blum
Needham
BuyMaintains
$44.00
Jason Zemansky
BofA Securities
SellReiterates
$12.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Sep 25, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for LYEL?

The analyst consensus rating for LYEL is Buy, based on the latest ratings from 5 analysts over the last 90 days.

What is the average price target for LYEL?

The average 12-month price target for LYEL is $36.20, representing an upside of 288.8% from the Oct 26, 2026 close of $9.31.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.